Sign In
Forgot Password?
ehaweb.org
Search
Loading
Navbar input
WAIT FOR SUGGESTIONS BY CATEGORY
OR CONTINUE TYPING IN YOUR KEYWORDS
ENTER ONE OR MULTIPLE KEYWORDS &
PRESS THE SEARCH BUTTON
From
To
Search
Favorites
Advanced
Minimize
More ▾
Less ▸
Clear
Protected by US Patents
For full functionality of this site it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
.
TREATMENT-DEPENDENCE OF HIGH-RISK GENE EXPRESSION SIGNATURES IN DE NOVO FOLLICULAR LYMPHOMA
EHA Library, Christopher Bolen, 267301
GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY
EHA Library, Stephan Stilgenbauer, 267306
SCREENING OF CLUSTERED REGULATORY ELEMENTS REVEALS NOVEL LEUKEMIA DEPENDENCIES
EHA Library, Camille Lobry, 267311
POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT
EHA Library, Arnon Nagler, 267315
THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM
EHA Library, Mehmet Samur, 267320
SETD2 LOSS OF FUNCTION IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA INDUCED BY POST-TRANSLATIONAL MECHANISMS THAT CAN BE THERAPEUTICALLY TARGETED
EHA Library, Manuela Mancini, 267324
BCP- AND T-ALL CELLS HIDE IN DISTINCT NICHES OF THE BONE MARROW
EHA Library, Danaëlle Capron, 267329
BIOLOGICAL CHARACTERIZATION OF THE U2AF1 S34F MUTATION IN THE PATHOGENESIS OF MYELODYSPLASIA
EHA Library, Ayana Kon, 267333
REPROGRAMMING HEMATOPOIETIC STEM CELL FUNCTION VIA MODULATION OF MITOCHONDRIAL ACTIVITY
EHA Library, Mukul Girotra, 267337
RESULTS FROM THE PHASE 3 NORTHSTAR-3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSAEMIA AND A Β0 OR IVS-I-110 MUTATION AT BOTH ALLELES OF THE HBB GENE
EHA Library, Andreas E. Kulozik, 267341
Is iron chelation really necessary in MDS?
EHA Library, Eva Hellström- Lindberg, 274190
Epigenomic changes mediating leading risk scenarios for initiation and progression of cancers. Implications for prevention, interception and therapy
EHA Library, Stephen Baylin, 274189
DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESIS
EHA Library, Sofia Gialesaki, 274188
RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE
EHA Library, Jo Howard, 274185
TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICE
EHA Library, Antonella Nai, 274184
EBV infection - an hematological perspective
EHA Library, Olivier Hermine, 273679
The pathology of Epstein-Barr virus lymphoproliferations
EHA Library, Stefan Dojcinov, 273680
Management of posttransplant lymphoproliferative disorders
EHA Library, Daan Dierickx, 273681
Splenectomy and emerging novel treatments in rare inherited hemolytic anemias
EHA Library, Hannah Tamary, 273705
Hereditary spherocytosis and allied disorders
EHA Library, Roberta Russo, 273704
Red cell membrane proteins
EHA Library, Lesley Bruce, 273703
The impact of spliceosome mutations in MDS
EHA Library, Jacqueline Boultwood, 273697
The role of innate immunity in MDS pathogenesis
EHA Library, Alan List, 273698
High risk MDS after HMAs
EHA Library, Lionel ADES, 273699
Fibrosis driving myelofibroblast precursors in MPN & new therapeutic pathways
EHA Library, Rebekka Schneider, 273700
Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
EHA Library, Jyoti Nangalia, 273701
MF management
EHA Library, Srdan Verstovsek, 273702
Molecular driven DLBCL therapy: Ready for the prime time?
EHA Library, Marek Trneny, 273693
Molecular classification of aggressive B-cell lymphoma
EHA Library, Bjoern Chapuy, 273692
Aggressive B-cell lymphoma subtyping: a Pathologist's viewpoint
EHA Library, Daphne de Jong, 273691
Management of coagulation disorders in severe inflammation
EHA Library, Riitta Lassila, 273687
Disseminated intravascular coagulation - What can we do?
EHA Library, Cheng-Hock Toh, 273686
Platelet-neutrophil crosstalk and netosis
EHA Library, Konstantin Stark, 273685
Relevant subtypes in childhood ALL
EHA Library, Hélène Cavé, 273709
Opportunities and challenges of personalized therapy of patients with HR ALL
EHA Library, Shai Izraeli, 273710
Current Perspectives in T-ALL
EHA Library, Adolfo Ferrando, 273711
Treatment options for relapsed Waldenström's Macroglobulinemia
EHA Library, Christian Buske, 273678
Waldenström’s macroglobulinemia front line treatment
EHA Library, Alessandra Tedeschi, 273677
Genomic landscape of Waldenström’s macroglobulinemia
EHA Library, Steven Treon, 273676
Current treatment approaches in CML
EHA Library, Gianantonio Rosti, 273675
TKI safety
EHA Library, Henrike Hjorth-Hansen, 273674
NGS in CML - New standard diagnostic procedure?
EHA Library, Susan Branford, 273673
Targeting leukemia with HLA class II restricted T cells
EHA Library, Fred Falkenburg, 274215
ACQUIRED HEMOPHILIA AND MONOCLONAL GAMMOPATHY OF HEMOSTASIC SIGNIFICANCE
EHA Library, FERNANDO ESCALANTE BARRIGON, 267548
ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR IN A MILD HAEMOPHILIA A PATIENT: A CASE REPORT
EHA Library, Manuel Rodriguez Lopez, 267549
CONGENITAL COMBINED DEFECTS OF COAGULATION FACTORS FVII AND FX : ABOUT A TUNISIAN FAMILY.
EHA Library, Fatma Megdich, 267550
WHEN DO WE HAVE TO SUSPECT AND DIAGNOSE VON WILLEBRAND DISEASE?
EHA Library, Shin Young Hyun, 267551
HEPATITIS ASSOCIATED APLASTIC ANEMIA: ETIOLOGY, CLINICAL CHARACTERISTICS AND OUTCOME
EHA Library, Şebnem Yılmaz, 267552
PERSISTENT COMPLEMENT ACTIVATION IS PROVOKED BY IGG-AGGREGATES IN A SUB-POPULATION OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
EHA Library, Regina Michelis, 267553
IS THERE A ROLE OF VITAMIN D IN THE PATHOPHYSIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA?
EHA Library, Stavroula Ntoufa, 267554
EPISTAXIS IN PEDIATRIC TERTIARY OUT-PATIENT CLINIC: COULD IT BE AN ALARMING SIGN?
EHA Library, Fatma Soliman Ebeid, 267547
HIGH CXCR3 AND CXCR5 DISTINGUISH IGHVMUT FROM IGHVUNMUT CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CD5HIGH AND CD5LOW CLONES
EHA Library, Gabriela Gabcova, 267556
GENOMIC CHARACTERIZATION OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA: ROLE OF ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH)
EHA Library, Raquel Alves, 267557
VENETOCLAX ALONE OR IN COMBINATION WITH RITUXIMAB FOR JAPANESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Ryan Bourgo, 267558
CLINICO-BIOLOGICAL FEATURES AND OUTCOMES OF ACCELERATED PHASE CHRONIC LYMPHOCYTIC LEUKEMIA (AP-CLL) IN THE ERA OF TARGETED AGENTS.
EHA Library, Jacqueline Barrientos, 267559
REAL WORLD TREATMENT PERSISTENCE OF NEW ZEALAND IBRUTINIB CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN A NAMED PATIENT PROGRAM
EHA Library, Andrea PUIG, 267560
NON-INTERVENTIONAL RETROSPECTIVE MULTICENTER STUDY EVALUATING REAL WORD IDELALISIB USE IN CLL AND INHL PATIENTS ENROLLED IN THE FRENCH EARLY ACCESS PROGRAM (EAP)
EHA Library, Loic Ysebaert, 267561
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH INCREASED SERUM VON WILLEBRAND LEVELS AT DIAGNOSIS HAVE A SHORTER TIME TO TREATMENT
EHA Library, Annita-Ioanna Gkioka, 267562
MANAGEMENT OF AUTOIMMUNE CYTOPENIA COMPLICATING CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Maksym Semerak, 267563
PURGING WITH CHLORAMBUCIL TO PREVENT INFUSION-RELATED REACTIONS BEFORE OBINUTUZUMAB ADMINISTRATION: A MONOCENTRIC PILOT EXPERIENCE.
EHA Library, Idanna Innocenti, 267564
PONATINIB LONG-TERM FOLLOW-UP OF EFFICACY AND SAFETY IN CP-CML PATIENTS IN REAL WORLD SETTINGS IN FRANCE: THE POST-PACE STUDY
EHA Library, Gabriel Etienne, 267565
QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE AFTER STOPPING TREATMENT BY TYROSINE KINASE INHIBITORS AT LONG-TERM FOLLOW-UP
EHA Library, Tatiana Nikitina, 267566
LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING TREATMENT OF CML PATIENTS WITH IMATINIB – A RETROSPECTIVE ANALYSIS
EHA Library, Kostyantyn KOTLYARCHUK, 267567
DOES STEPWISE DOSE ESCALATION METHOD OF NILOTINIB FOR CML IMPROVE MR4.5 AND TREATMENT FREE REMISSION ?
EHA Library, Kohmei Kubo, 267568
REAL LIFE DATA OF NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT OR INTOLERANT TO IMATINIB
EHA Library, Tayfun Elibol, 267569
COEXISTENCE OF BCR/ABL1 AND JAK2 MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Ferdinando Frigeri, 267570
CHRONIC MYELOID LEUKEMIA DEVELOPING AFTER SYSTEMIC MASTOCYTOSIS: FAST AND COMPLETE MOLECULAR RESPONSE INDUCED BY IMATINIB.
EHA Library, Juan Luis Steegmann, 267571
PRALATREXATE EXPERIENCE IN NON HODGKIN LYMPHOMA
EHA Library, Leonardo Enciso-Olivera, 267546
SEZARY SYNDROME TREATMENT AND OTHER T-CELL CUTANEOUS LYMPHOMAS WITH EXTRACORPOREAL PHOTOPHERESIS: RESULTS FROM 157 PROCEDURES IN ELEVEN PATIENTS IN COLOMBIA
EHA Library, Leonardo Enciso-Olivera, 267545
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)
EHA Library, Guillaume Germain, 267544
CLINICAL FEATURES AND PROGNOSTIC FACTORS OF PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA (PT-DLBCL): EXPERIENCE OF 35 PATIENTS FROM FUSCC
EHA Library, Fang-Fang Lv, 267543
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)
EHA Library, Guillaume Germain, 267542
OUTCOME OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION IN PATIENTS WITH LOW-RISK PERIPHERAL T-CELL LYMPHOMAS (PTCLS)
EHA Library, Haiwen Huang, 267541
INCREASED RISK OF HIP FRACTURES IN YOUNG WOMEN WITH LYMPHOMA, RESULTS FROM A SWEDISH POPULATION BASED STUDY
EHA Library, Peter Johansson, 267540
HOW TO PREDICT EARLY PROGRESSION IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Aya Nakaya, 267539
DURABILITY OF COMPLETE RESPONSE AFTER BLINATUMOMAB THERAPY FOR REFRACTORY/RELAPSED AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA
EHA Library, Carine Thual, 267538
PROGRAMMED CELL DEATH-1 AND PROGRAMMED CELL DEATH LIGANDS EXPRESSION IN NODAL PERIPHERAL T-CELL LYMPHOMA
EHA Library, Kitsada Wudhikarn, 267537
TWO-YEAR SURVIVAL WITH AXICABTAGENE CILOLEUCEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: AN UPDATED ANALYSIS
EHA Library, Tiffany Adolf, 267536
THE ANALYSIS OF GENE MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA
EHA Library, Natallia Klimkovich, 267534
CHILDHOOD ACUTE MYELOID LEUKEMIA IN SOUTHERN TUNISIA: ABOUT 52 CASES
EHA Library, olfa kassar, 267533
REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS- SINGLE INSTITUTION EXPERIENCE FROM INDIA
EHA Library, CHETHAN R, 267532
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IMPROVES SURVIVAL IN AML PATIENTS WITH HIGH FLT3-ITD ALLELIC RATIO
EHA Library, Apostolia Papalexandri, 267531
ASSESSMENT OF FLT3 MUTATION IN ACUTE MYELOID LEUKEMIA: RESULTS OF A SPANISH DELPHI PANEL SURVEY
EHA Library, Jorge Sierra, 267530
CLINICAL FEATURES AND TREATMENT OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
EHA Library, olfa kassar, 267529
THE ROLE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA: THE EFFECT ON THE COURSE OF THE DISEASE AND THE RESULTS OF THERAPY
EHA Library, Asiyat Radzhabova, 267528
A SIMPLE FLOW CYTOMETRY-BASED SCORE MAY OPTIMIZE TESTING FOR BIALLELIC CEBPA MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Fabio Guolo, 267526
EVOLUTION OF EFFICACY IN APL TREATMENT WITHIN RUSSIAN MULTICENTER TRIALS 1992-2019.
EHA Library, Olga Aleshina Gavrilina, 267525
STUDY ON MECHANISM OF MATERIA MEDICA HEDYOTIS DIFFUSA REGULATING MITOCHONDRIAL MORPHOLOGY AND FUNCTION TO INDUCE APOPTOSIS IN KG1A CELLS
EHA Library, Ruirong Xu, 267523
PROGNOSTIC IMPACT OF ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA
EHA Library, Ines Turki, 267522
THERAPEUTIC POTENCIAL OF GAMBOGIC ACID AND SILIBININ IN ACUTE MYELOBLASTIC LEUKEMIA – IN VITRO STUDIES
EHA Library, Raquel Alves, 267521
PPP1R15A GENE IS OVEREXPRESSED IN CHEMORESISTANT ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Frieda KONTSIOTI, 267520
ANALYSIS OF MICRO-RNAS EXPRESSION PROFILE IN EXOSOMES DERIVED FROM ACUTE MYELOID LEUKEMIA BY KNOCKDOWN P62 AND THE EFFECT ON ANGIOGENESIS
EHA Library, Hu R, 267519
SUCCESSFUL HAPLOIDENTIC BONE MARROW TRANSPLANTATION WITH INOTUZUMAB OZOGAMICIN IN PATIENT WITH RELAPSED AND RESISTANT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ali Ünal, 267518
ADULT ACUTE LEUKEMIA AND SEASONALITY: A SINGLE CENTER EXPERIENCE
EHA Library, Derya Sahin, 267517
OUTCOME OF PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ALL IN SOUTHERN TUNISIA: ABOUT 13 CASES
EHA Library, Imen Frikha, 267516
BONE MARROW NECROSIS IN A PATIENT FOLLOWING BLINATUMOMAB THERAPY
EHA Library, Nese Yarali, 267515
FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA.
EHA Library, Imen Frikha, 267514
ABERRANT EZH2 HIGH EXPRESSION IN THE PATIENTS WITH ACUTE LEUKEMIA AND EFFECT OF A NOVEL EZH2 INHIBITOR GSK126 ON CELL PROLIFERATION AND APOPTOSIS OF THE MALIGNANT CELLS
EHA Library, Chunhua song, 267513
EXOSOMES-MEDIATED DELIVERY OF RNA OLIGOS DIRECTED TO CHE-1/AATF IMPAIRS BCP-ALL VITALITY
EHA Library, Matteo Caforio, 267512
MULTIPARAMETRIC FLOW-CYTOMETRY ANALYSIS OF SURFACE MARKERS EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: PATHOGENIC AND PROGNOSTIC IMPLICATIONS.
EHA Library, Umberto Falcone, 267555
«
...
173
174
175
176
177
178
179
180
181
...
»